Litcius/Paper detail

SARS-CoV-2 Infection of Airway Cells

Camille Ehré

2020New England Journal of Medicine32 citationsDOIOpen Access PDF

Abstract

In a laboratory setting, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was inoculated into human bronchial epithelial cells. This inoculation, which was performed in a biosafety level 3 facility, had a multiplicity of infection (indicating the ratio of virus particles to targeted airway cells) of 3:1. These cells were then examined 96 hours after infection with the use of scanning electron microscopy. An en face image (Panel A) shows an infected ciliated cell with strands of mucus attached to the cilia tips. At higher magnification, an image (Panel B) shows the structure and density of SARS-CoV-2 virions produced by human airway epithelial cells. Virus production was approximately 3×106 plaque-forming units per culture, a finding that is consistent with a high number of virions produced and released per cell. Camille Ehre, Ph.D.Baric and Boucher Laboratories at University of North Carolina School of Medicine, Chapel Hill, NC [email protected]

Topics & Concepts

Multiplicity of infectionVirologyRespiratory systemMucusVirusAirwayCoronavirusSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Cell cultureRespiratory epitheliumBiologyPathologyCoronavirus disease 2019 (COVID-19)MedicineAnatomyInfectious disease (medical specialty)DiseaseEcologyGeneticsSurgeryRespiratory viral infections researchSARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testing